The Algae4IBD project is exploring the untapped potential of algae and cyanobacteria to manage inflammatory bowel disease (IBD) ...
The first global consensus on inflammatory bowel disease and pregnancy delivers clinician-focused, evidence-based guidance for real-world practice.
Subcutaneous vedolizumab dose intensification restored steroid-free clinical response in approximately one-third of patients with IBD.
Pharmaceutical Technology on MSN
McMaster University and MIT discover new antibiotic for IBD
Discovered at McMaster, the newly identified antibiotic presents a potential new therapy for individuals living with Crohn's disease.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback